Global Health Shake-Up: Key Developments in Pharma and Governance
Recent health-related developments highlight significant shifts in the pharma industry and governance: France's Carmat files for insolvency, the FDA updates warnings on ADHD drugs, and the U.S. House issues a subpoena over delayed COVID vaccine results. Includes acquisition news by India’s Torrent Pharmaceuticals.
In a turbulent start to the week for the pharmaceutical sector, French company Carmat has filed for insolvency, citing a lack of emergency funding. This led to the suspension of its shares, pending a court decision.
In the United States, the Supreme Court has asked for the solicitor general's input on Bayer's case involving the weedkiller glyphosate, while the FDA plans to update ADHD drug labels to include risks for young children. Additionally, the U.S. House Judiciary Committee has issued a subpoena to a former Pfizer executive regarding COVID vaccine trial delays.
Meanwhile, Moderna's flu vaccine shows promising results, outperforming GSK's, and India's Torrent Pharmaceuticals announces plans to acquire JB Chemicals. These developments indicate a dynamic shift in global health governance and pharmaceutical practices.
(With inputs from agencies.)
- READ MORE ON:
- pharmaceutical
- health
- insolvency
- glyphosate
- ADHD
- Moderna
- FDA
- vaccine
- subpoena
- Torrent Pharmaceuticals
ALSO READ
Unveiling the Superpowers of ADHD in the Workplace
Mysterious Demise: Undertrial Prisoner Dies in Safdarjung Hospital
Alembic Pharmaceuticals Gains USFDA Nod for Cancer Fighting Injection
Carmat's Insolvency, FDA's ADHD Drug Warning, and More: Key Health News Updates
BJP legislator says banned gutka easily accessible in Maharashtra, slams FDA
Google News